Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel 5-HT2A inverse agonist shows in vivo efficacy in models of thrombosis

April 9, 2008

Visual stability seen with pegaptanib maintenance therapy in neovascular AMD

April 9, 2008

Ranibizumab under study in patients with pigment epithelial detachments

April 9, 2008

Reduced retinal thickness seen with VEGF Trap-Eye in neovascular AMD

April 9, 2008

Recent data on bevacizumab in ocular disorders presented

April 9, 2008

Modafinil improves cocaine abstinence in some addicted patients

April 9, 2008

Improved pharmacokinetics of second-generation FBPase inhibitor for the treatment of diabetes

April 8, 2008

Intravitreal JSM-6427 well tolerated in age-related macular degeneration patients

April 8, 2008

Human ApoB-100 related peptide vaccine effects modulated by dose, diet timing

April 8, 2008

In vivo efficacy of BMS-641988, a novel androgen receptor antagonist

April 8, 2008

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...